Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-20

Clinical Trial Update: Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an antibiotic as an enhancer to treat social anxiety disorder has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Phobic Disorders, Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2014-05-20